Clinical Evaluation on the Longevity of Glass Ceramic Based Single Tooth Restorations
Launched by IVOCLAR VIVADENT AG · Mar 20, 2025
Trial Information
Current as of April 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age: \> 18 years
- • Informed consent signed and understood by the subject
- • Received indirect single tooth restoration (inlay, onlay, veneer or crown) within the internal clinic of Ivoclar Vivadent AG between 2006 and 2010
- • Single tooth restoration was done with IPS e.max CAD or IPS e.max Press
- • Able to visit the internal clinic of Ivoclar Vivadent AG in Schaan, FL.
- Exclusion Criteria:
- • Health status (physical and mental) does not allow participation
About Ivoclar Vivadent Ag
Ivoclar Vivadent AG is a leading global manufacturer of innovative dental materials and equipment, dedicated to enhancing oral health and aesthetics. With a strong emphasis on research and development, the company focuses on creating high-quality solutions that meet the evolving needs of dental professionals and their patients. Ivoclar Vivadent AG is committed to advancing dental science through rigorous clinical trials, ensuring the efficacy and safety of its products while fostering a culture of excellence and sustainability in oral healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Schaan, , Liechtenstein
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Related Blog Entries
View all
